These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31471732)
1. Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma. El-Hamouly MS; Azzam AA; Ghanem SE; El-Bassal FI; Shebl N; Shehata AMF Mol Biol Rep; 2019 Dec; 46(6):5759-5765. PubMed ID: 31471732 [TBL] [Abstract][Full Text] [Related]
2. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients. Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924 [TBL] [Abstract][Full Text] [Related]
3. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage. Sun Q; Li J; Jin B; Wang T; Gu J Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500 [TBL] [Abstract][Full Text] [Related]
5. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients. Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493 [TBL] [Abstract][Full Text] [Related]
6. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
7. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma. El Mahdy HA; Abdelhamid IA; Amen AI; Abdelsameea E; Hassouna MM Asian Pac J Cancer Prev; 2019 Sep; 20(9):2723-2731. PubMed ID: 31554369 [TBL] [Abstract][Full Text] [Related]
9. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041 [TBL] [Abstract][Full Text] [Related]
10. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage. Lin L; Lu B; Yu J; Liu W; Zhou A Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963 [TBL] [Abstract][Full Text] [Related]
11. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma. Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589 [TBL] [Abstract][Full Text] [Related]
12. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients. Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740 [TBL] [Abstract][Full Text] [Related]
13. Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma. Shen X; Xue Y; Cong H; Wang X; Ju S Ann Clin Biochem; 2018 Jul; 55(4):478-484. PubMed ID: 29065698 [TBL] [Abstract][Full Text] [Related]
14. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Li L; Guo Z; Wang J; Mao Y; Gao Q Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399 [TBL] [Abstract][Full Text] [Related]
15. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
16. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model. Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667 [TBL] [Abstract][Full Text] [Related]
17. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
18. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors. Franck M; Schütte K; Malfertheiner P; Link A World J Gastroenterol; 2020 Jan; 26(1):86-96. PubMed ID: 31933516 [TBL] [Abstract][Full Text] [Related]
20. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients. Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]